Poland· PL-100281734
Levebon
A levetiracetam product containing levetiracetamum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Levetiracetam is registered in 19 of 19 countries.
Countries holding a registration under ATC N03AX14 (levetiracetam), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Levetiracetam · ATC N03AX14
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levetiracetam costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), the median price runs from $1.19 in France to $3.10 in Spain — a ×2.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levetiracetam · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- ES Spain$3.10
- CH Switzerland$2.54
- IT Italy$2.14
- FR France$1.19
The record
At a glance
URPL (Poland)- Active substance
- Levetiracetamum
- Manufacturer
- G.L. Pharma GmbH
- Country
- Poland (PL)
- ATC code
- N03AX14
- ATC class
- Levetiracetam
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 18
1 priced- gtin05909990989775
- gtin05909990989782
- gtin05909990989799
- gtin05909990989829
- gtin05909990989836
- gtin0590999098980550 szt.PLN 58.8
- gtin05909990989843
- gtin05909990989850
- gtin05909990989867
- gtin05909990989874
- gtin05909990989881
- gtin05909990989898
- gtin05909990989904
- gtin05909990989973
- gtin05909990989980
- gtin05909990989997
- gtin05909990990009
- gtin05909990990061
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
258 interactions on record for levetiracetam.
Graded by severity as the source publishes them — 50 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levetiracetam · interactions on record
258 records
- 50 moderate
- 3 minor
- 164 info
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
41 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Levetiracetam in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDRETACENSandoz s.r.o., Praha
- SpainKEPPRA 1000 mg COMPRIMIDOS RECUBIERTOS CON PELICULAUcb Pharma
- United StatesKeppraUCB, Inc.
- SwedenKeppra 1000 mg Filmdragerad tablettUCB Pharma S.A.
- BelgiumKeppra 1000 mgPI Pharma
- SwitzerlandLevetiracetam Desitin 1000 mg, befilmtes Granulat im BeutelDesitin Pharma GmbH
- ItalyEPITIRAMNEURAXPHARM ITALY S.P.A.
- FinlandKeppraUCB Pharma SA
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Levebon, Levetiracetam +pharma
- Belgium · Larofec, Levetiracetam A.Forall
- Bulgaria · Levebon, Леветиракон Pharmacons
- Cyprus · Levetiracetam Noridem, Lyberen
- Czechia · Dretacen, Epiletam
- Germany · Levetiracetam 1 A Pharma, Levetiracetam Aaa
- Denmark · Kevesy, Levetiracetam ”1a Farma”
- Estonia · Levetiracetam Zentiva, Normeg
- Spain · Laurak, Levetiracetam Almus
- Finland · Larofec, Levetiracetam 1a Farma
- France · Levetiracetam Accord, Levetiracetam Aguettant
- United Kingdom (Northern Ireland) · Desitrend, Genlev
- Greece · Ession, Kepricet
- Croatia · Levetiracetam Kalceks, Lyvam
- Hungary · Epiletam, Levetiracetam Kabi
- Ireland · Larofec, Levetiracetam Brillpharma
- Iceland · Keppra, Levetiracetam Accord
- Italy · Epitiram, Grifoxina
- Liechtenstein · Keppra, Levetiracetam Accord
- Lithuania · Dretacen, Levetiracetam Kalceks
- Luxembourg · Larofec, Levetiracetam Micro Labs
- Latvia · Levetiracetam Kalceks
- Malta · Levetiracetam Accord, Levetiracetam Aurobindo
- Netherlands · Dretacen, Larofec
- Norway · Keppra, Larofec
- Portugal · Cinaz, Laurak
- Romania · Levetiracetam Accord, Levetiracetam Arena
- Sweden · Levebon, Levetiracetam
- Slovenia · Levetiracetam Kalceks
- Slovakia · Epiletam, Levetiracetam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ada9ffb9-ff0e-4dc3-b7ec-f54c1ed25a0b GET /v1/drugs/ada9ffb9-ff0e-4dc3-b7ec-f54c1ed25a0b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "1000 mg",
"packaging": "05909990989775 ¦ Rp ¦ 77709\n10 tabl. w blistrze\n05909990989782 ¦ Rp ¦ 77710\n20 tabl. w blistrze\n05909990989799 ¦ Rp ¦ 77711\n30 tabl. w blistrze\n05909990989805 ¦ Rp ¦ 77712\n50 tabl. w blistrze\n05909990989829 ¦ Rp ¦ 77713\n60 tabl. w blistrze\n05909990989836 ¦ Rp ¦ 77714\n90 tabl. w blistrze\n05909990989843 ¦ Rp ¦ 77715\n100 tabl. w blistrze\n05909990989850 ¦ Rp ¦ 77716\n120 tabl. w blistrze\n05909990989867 ¦ Rp ¦ 77717\n200 tabl. w blistrze\n05909990989874 ¦ Rp ¦ 77718\n10 tabl. w butelce\n05909990989881 ¦ Rp ¦ 77719\n20 tabl. w butelce\n05909990989898 ¦ Rp ¦ 77720\n30 tabl. w butelce\n05909990989904 ¦ Rp ¦ 77721\n50 tabl. w butelce\n05909990989973 ¦ Rp ¦ 77722\n60 tabl. w butelce\n05909990989980 ¦ Rp ¦ 77723\n90 tabl. w butelce\n05909990989997 ¦ Rp ¦ 77725\n100 tabl. w butelce\n05909990990009 ¦ Rp ¦ 77726\n120 tabl. w butelce\n05909990990061 ¦ Rp ¦ 77727\n200 tabl. w butelce",
"substance": "Levetiracetamum 1000 mg",
"common_name": "Levetiracetamum",
"pl_product_id": "100281734",
"pozwolenie_nr": "20292",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about levetiracetam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.